STAT stories you may have missed

STAT’s Matt Herper speaks to Sanofi’s newly minted CEO. 

What we know—and still don’t know—about Covid-19.

CureVac is the latest vaccine maker to see their value soar amid the coronavirus pandemic. 

Disability advocates are at the forefront of the 2020 presidential race

STAT exclusive: Inside the federal government’s botched plan to give away millions of masks.

State efforts to cap out of pocket costs for speciality drugs are working, a new analysis finds  

The lobbying organization for medical schools funneled $500,000 to a dark money group pitted against pharma.